As of 2025-05-07, the Relative Valuation of US Stem Cell Inc (USRM) is (0.02) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.00 USD, the upside of US Stem Cell Inc based on Relative Valuation is -12574.1%.
The range of the Relative Valuation is (0.02) - (0.03) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.5x - 6.2x | 5.6x |
| Forward P/E multiples | 4.5x - 8.8x | 5.6x |
| Fair Price | (0.02) - (0.03) | (0.02) |
| Upside | -10079.3% - -13955.2% | -12574.1% |
| Date | P/E |
| 2025-04-25 | -0.02 |
| 2025-04-24 | -0.02 |
| 2025-04-23 | -0.02 |
| 2025-04-21 | -0.02 |
| 2025-04-17 | -0.02 |
| 2025-04-16 | -0.02 |
| 2025-04-14 | -0.02 |
| 2025-04-08 | -0.02 |
| 2025-04-07 | -0.02 |
| 2025-04-04 | -0.02 |
| 2025-04-02 | -0.02 |
| 2025-04-01 | -0.02 |
| 2025-03-31 | -0.02 |
| 2025-03-21 | -0.02 |
| 2025-03-20 | -0.02 |
| 2025-03-19 | -0.02 |
| 2025-03-17 | -0.02 |
| 2025-03-14 | -0.02 |
| 2025-03-07 | -0.02 |
| 2025-03-06 | -0.02 |
| 2025-03-05 | -0.04 |
| 2025-03-04 | -0.04 |
| 2025-03-03 | -0.02 |
| 2025-02-26 | -0.02 |
| 2025-02-25 | -0.02 |
| 2025-02-24 | -0.02 |